Effects of DM-9384, a pyrrolidone derivative, on alcohol- and chlordiazepoxide-induced amnesia in mice
- PMID: 2113296
- DOI: 10.1016/0091-3057(90)90396-y
Effects of DM-9384, a pyrrolidone derivative, on alcohol- and chlordiazepoxide-induced amnesia in mice
Abstract
The effects of N-(2,6-dimethyl-phenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide (DM-9384), a new pyrrolidone derivative, were investigated on ethanol- and chlordiazepoxide (CDP)-induced amnesia animal model using the passive avoidance task in comparison with aniracetam, another pyrrolidone derivative. Pretraining administration of DM-9384 attenuated ethanol- and CDP-induced amnesia, whereas aniracetam failed to do so. The effects of DM-9384 on CDP-induced amnesia were antagonized by bicuculline, a GABAA receptor antagonist, but not by scopolamine, a muscarinic acetylcholine receptor antagonist and flumazenil, a benzodiazepine receptor antagonist. These results suggest that DM-9384 attenuates CDP-induced amnesia by interacting with the GABAergic neuronal system.
Similar articles
-
Effects of DM-9384, a cyclic derivative of GABA, on amnesia and decreases in GABAA and muscarinic receptors induced by cycloheximide.J Pharmacol Exp Ther. 1991 Apr;257(1):271-5. J Pharmacol Exp Ther. 1991. PMID: 1850466
-
Effects of DM-9384 in a model of amnesia based on animals with GABAergic neuronal dysfunctions.Eur J Pharmacol. 1990 Mar 20;178(2):143-9. doi: 10.1016/0014-2999(90)90469-m. Eur J Pharmacol. 1990. PMID: 2328758
-
Development of tolerance to amnesic effects of chlordiazepoxide in relation to GABAergic and cholinergic neuronal systems.Eur J Pharmacol. 1993 Jan 19;230(3):313-20. doi: 10.1016/0014-2999(93)90567-2. Eur J Pharmacol. 1993. PMID: 8382617
-
Involvement of the cholinergic system in the effects of nefiracetam (DM-9384) on carbon monoxide (CO)-induced acute and delayed amnesia.Eur J Pharmacol. 1992 Jun 5;216(2):279-85. doi: 10.1016/0014-2999(92)90371-a. Eur J Pharmacol. 1992. PMID: 1397012
-
Animal model studies of benzodiazepine-induced amnesia.Psychopharmacol Ser. 1988;6:218-29. doi: 10.1007/978-3-642-73288-1_16. Psychopharmacol Ser. 1988. PMID: 2905807 Review.
Cited by
-
Aniracetam. An overview of its pharmacodynamic and pharmacokinetic properties, and a review of its therapeutic potential in senile cognitive disorders.Drugs Aging. 1994 Mar;4(3):257-73. doi: 10.2165/00002512-199404030-00007. Drugs Aging. 1994. PMID: 8199398 Review.
-
Reversal effect of DM-9384 on scopolamine-induced acetylcholine depletion in certain regions of the mouse brain.Psychopharmacology (Berl). 1991;105(3):310-6. doi: 10.1007/BF02244423. Psychopharmacology (Berl). 1991. PMID: 1798828
-
Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part I.Psychopharmacology (Berl). 1992;107(2-3):144-59. doi: 10.1007/BF02245132. Psychopharmacology (Berl). 1992. PMID: 1615119 Review.
-
A possible mechanism for improvement by a cognition-enhancer nefiracetam of spatial memory function and cAMP-mediated signal transduction system in sustained cerebral ischaemia in rats.Br J Pharmacol. 2003 Feb;138(4):642-54. doi: 10.1038/sj.bjp.0705096. Br J Pharmacol. 2003. PMID: 12598418 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources